JP2008545686A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008545686A5 JP2008545686A5 JP2008513411A JP2008513411A JP2008545686A5 JP 2008545686 A5 JP2008545686 A5 JP 2008545686A5 JP 2008513411 A JP2008513411 A JP 2008513411A JP 2008513411 A JP2008513411 A JP 2008513411A JP 2008545686 A5 JP2008545686 A5 JP 2008545686A5
- Authority
- JP
- Japan
- Prior art keywords
- methoxy
- dimethylamino
- dihydro
- chromen
- tetrahydronaphthalen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0501166 | 2005-05-23 | ||
| SE0501168 | 2005-05-23 | ||
| PCT/SE2006/000593 WO2006126939A1 (en) | 2005-05-23 | 2006-05-22 | Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008545686A JP2008545686A (ja) | 2008-12-18 |
| JP2008545686A5 true JP2008545686A5 (enExample) | 2009-07-09 |
Family
ID=37452274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008513411A Pending JP2008545686A (ja) | 2005-05-23 | 2006-05-22 | ５ｈｔ６受容体を調節する新規な８−スルホニルアミノ−３アミノ置換クロマンまたはテトラヒドロナフタレン誘導体 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090030038A1 (enExample) |
| EP (1) | EP1888517A1 (enExample) |
| JP (1) | JP2008545686A (enExample) |
| KR (1) | KR20080016810A (enExample) |
| AR (1) | AR054363A1 (enExample) |
| AU (1) | AU2006250117A1 (enExample) |
| BR (1) | BRPI0610119A2 (enExample) |
| CA (1) | CA2609747A1 (enExample) |
| IL (1) | IL187099A0 (enExample) |
| MX (1) | MX2007014263A (enExample) |
| NO (1) | NO20076638L (enExample) |
| TW (1) | TW200716529A (enExample) |
| WO (1) | WO2006126939A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7754148B2 (en) | 2006-12-27 | 2010-07-13 | Progentech Limited | Instrument for cassette for sample preparation |
| US7727473B2 (en) | 2005-10-19 | 2010-06-01 | Progentech Limited | Cassette for sample preparation |
| MX2010002938A (es) | 2007-09-24 | 2010-04-01 | Comentis Inc | Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer. |
| JP2011505418A (ja) | 2007-12-04 | 2011-02-24 | メルク・シャープ・エンド・ドーム・コーポレイション | ５−ｈｔ６アンタゴニストとしてのトリプタミンスルホンアミド |
| EP2116546A1 (en) | 2008-05-09 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | Substituted N-phenyl-2,3-dihydroimidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-HT6 ligands |
| EP2116547A1 (en) | 2008-05-09 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | Substituted N-imidazo(2, 1-b) thiazole-5-sulfonamide derivatives as 5-TH6 ligands |
| KR101643196B1 (ko) * | 2010-02-23 | 2016-07-27 | 루미넥스 코포레이션 | 일체화된 샘플 제조, 반응 및 검출을 위한 장치 및 방법 |
| US9248422B2 (en) | 2010-02-23 | 2016-02-02 | Luminex Corporation | Apparatus and methods for integrated sample preparation, reaction and detection |
| CA2797694A1 (en) | 2010-04-29 | 2011-11-03 | The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services | Activators of human pyruvate kinase |
| JP5641436B2 (ja) * | 2011-03-28 | 2014-12-17 | 国立大学法人 鹿児島大学 | 抗ｈｉｖ薬 |
| WO2015158313A1 (en) * | 2014-04-19 | 2015-10-22 | Sunshine Lake Pharma Co., Ltd. | Sulfonamide derivatives and pharmaceutical applications thereof |
| US10385040B2 (en) | 2014-08-12 | 2019-08-20 | Loyola University Of Chicago | Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same |
| WO2019058393A1 (en) | 2017-09-22 | 2019-03-28 | Jubilant Biosys Limited | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF PAD |
| FI3697785T3 (fi) | 2017-10-18 | 2023-04-03 | Jubilant Epipad LLC | Imidatsopyridiiniyhdisteitä pad:n estäjinä |
| AU2018362046B2 (en) | 2017-11-06 | 2023-04-13 | Jubilant Prodel LLC | Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation |
| BR112020010322A2 (pt) | 2017-11-24 | 2020-11-17 | Jubilant Episcribe Llc | composto da fórmula i; composto da fórmula ia; composto da fórmula ib; processo de preparação de compostos da fórmula i; composição farmacêutica; método para o tratamento e/ou prevenção de várias doenças; uso dos compostos; método para o tratamento de câncer; e método para o tratamento e/ou prevenção de uma afecção mediada por prmt5 ou um distúrbio proliferativo ou câncer |
| CN112105610B (zh) | 2018-03-13 | 2024-01-26 | 朱比连特普罗德尔有限责任公司 | 作为pd1/pd-l1相互作用/活化的抑制剂的双环化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2752659A1 (de) * | 1976-12-07 | 1978-06-08 | Sandoz Ag | Neue tetralinderivate, ihre herstellung und verwendung |
| CH637363A5 (en) * | 1977-11-24 | 1983-07-29 | Sandoz Ag | Process for preparing novel 2-aminotetralins |
| EP0994862B1 (en) * | 1997-07-11 | 2005-06-01 | SmithKline Beecham plc | Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| CA2461381A1 (en) * | 2001-10-04 | 2003-04-10 | Wyeth | Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| ES2529720T3 (es) * | 2004-10-14 | 2015-02-25 | Abbvie Deutschland Gmbh & Co Kg | Compuestos aromáticos sustituidos con arilsulfonilmetilo o arilsulfonamida adecuados para tratar trastornos que responden a la modulación del receptor de dopamina D3 |
-
2006
- 2006-05-18 AR ARP060102013A patent/AR054363A1/es not_active Application Discontinuation
- 2006-05-22 MX MX2007014263A patent/MX2007014263A/es not_active Application Discontinuation
- 2006-05-22 KR KR1020077027167A patent/KR20080016810A/ko not_active Withdrawn
- 2006-05-22 CA CA002609747A patent/CA2609747A1/en not_active Abandoned
- 2006-05-22 BR BRPI0610119-4A patent/BRPI0610119A2/pt not_active IP Right Cessation
- 2006-05-22 AU AU2006250117A patent/AU2006250117A1/en not_active Abandoned
- 2006-05-22 WO PCT/SE2006/000593 patent/WO2006126939A1/en not_active Ceased
- 2006-05-22 EP EP06747797A patent/EP1888517A1/en not_active Withdrawn
- 2006-05-22 JP JP2008513411A patent/JP2008545686A/ja active Pending
- 2006-05-22 US US11/915,173 patent/US20090030038A1/en not_active Abandoned
- 2006-05-23 TW TW095118301A patent/TW200716529A/zh unknown
-
2007
- 2007-11-01 IL IL187099A patent/IL187099A0/en unknown
- 2007-12-21 NO NO20076638A patent/NO20076638L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008545686A5 (enExample) | ||
| US6515002B2 (en) | Compounds and compositions for treating C1s-mediated diseases and conditions | |
| CA2787121C (en) | Aminopyridine derivatives as anti-malarial agents | |
| RU2576036C2 (ru) | Модуляторы активности нес1 и способы для них | |
| RU2007107189A (ru) | Производные арилпиридина | |
| RU2011147185A (ru) | Азетидинилдиамиды в качестве ингибиторов моноацилглицерин-липазы | |
| JP2013517273A5 (enExample) | ||
| JP2013525293A5 (enExample) | ||
| JP2008524244A5 (enExample) | ||
| TW201522306A (zh) | 雜環衍生物及其用途 | |
| JP2005505586A5 (enExample) | ||
| WO2002028353A2 (en) | Phosphate transport inhibitors | |
| RU2007107349A (ru) | Пиперазиновые производные, применение для лечения желудочно-кишечных расстройств | |
| US20090215764A1 (en) | Antimicrobial agents | |
| CN107108478A (zh) | Urat1抑制剂 | |
| JP2005514432A5 (enExample) | ||
| JP2003531201A (ja) | 炎症を治療するための２−フルオロベンゼンスルホニル化合物 | |
| CA2582276A1 (en) | Alkil-pyridines as 11-beta inhibitors for diabetes | |
| JP2002536446A (ja) | プロテアーゼ阻害剤としての、ヘテロアリールアミジン類、メチルアミジン類およびグアニジン類 | |
| CA2859024C (en) | Benzisothiazol-3(1h)-one-5-sulfonyl derivatives as chemokine receptor modulators | |
| US9603834B2 (en) | 1,2- bis-sulfonamide derivatives as chemokine receptor modulators | |
| JP2016518428A5 (enExample) | ||
| JP2008115166A5 (enExample) | ||
| CN101203504B (zh) | 抗微生物剂 | |
| RU2007131275A (ru) | Производные n-[(4, 5-дифенил-2-тиенил)метил]сульфонамида, их получение и их применение в терапии |